pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 545 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
olomorasib
Non-Small Cell Lung Cancer
Eli Lilly and Co
0 catalysts
Phase 3
olpasiran
Atherosclerosis
LPA mRNA
$AMGNAMGEN INC
0 catalysts
Phase 3
olverembatinib
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Bcr/Abl fusion protein
$AAPGASCENTAGE PHARMA GROUP INTERNATIONAL
← prev
page 14 of 19
next →
131
Pain89
Neurology1
0 catalysts
Phase 3
olvimulogene nanivacirepvec
Endometrial Cancer
$GNLXGENELUX Corp
0 catalysts
Phase 3
omidubicel
Omisirge (omidubicel-onlv)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Gamida Cell Ltd
0 catalysts
Phase 3
onfekafusp alfa
onfekafusp alfa [INN]
Soft Tissue Sarcoma
Philogen SpA
0 catalysts
Phase 3
onvuzosiran sodium
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
ADARx Pharmaceuticals Inc
0 catalysts
Phase 3
opiranserin
opiranserin [INN]
Post-Operative Pain
Vivozon Inc
0 catalysts
Phase 3
oregovomab
Ovarex (oregovomab)
Fallopian Tube Cancer
Mucin-16
OncoQuest Inc
0 catalysts
Phase 3
orelabrutinib
Primary Progressive Multiple Sclerosis (PPMS)
Tyrosine-protein kinase BTK
$ZBIOZenas BioPharma, Inc.
0 catalysts
Phase 3
osivelotor
Sickle Cell Disease
$PFEPFIZER INC
0 catalysts
Phase 3
pabinafusp alfa
pabinafusp alfa [INN]
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
JCR Pharmaceuticals Co Ltd
0 catalysts
Phase 3
padeliporfin potassium
Transitional Cell Cancer (Urothelial Cell Cancer)
ImPact Biotech Limited
0 catalysts
Phase 3
palazestrant
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$OLMAOlema Pharmaceuticals, Inc.
0 catalysts
Phase 3
paridiprubart
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
$EDSAEdesa Biotech, Inc.
0 catalysts
Phase 3
paromomycin
Paromomycin Sulfate (paromomycin [INN])
Leishmaniasis
Appili Therapeutics Inc
0 catalysts
Phase 3
pasritamig
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$JNJJOHNSON & JOHNSON
0 catalysts
Phase 3
patidegib hydrochloride
Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndr…
$SLGLSol-Gel Technologies Ltd.
0 catalysts
Phase 3
patritumab deruxtecan
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Receptor tyrosine-protein kinase erbB-3DNA topoisomerase 1
Daiichi Sankyo Co Ltd
0 catalysts
Phase 3
paxalisib
Recurrent Glioblastoma Multiforme (GBM)
PI3-kinase class I
$KZIAKAZIA THERAPEUTICS LTD
0 catalysts
Phase 3
peginterferon lambda-1a
Coronavirus Disease 2019 (COVID-19)
Interferon lambda receptor
Eiger Inno Therapeutics Inc
0 catalysts
Phase 3
pegozafermin
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
89bio Inc
0 catalysts
Phase 3
pegtibatinase
Homocystinuria
$TVTXTravere Therapeutics, Inc.
0 catalysts
Phase 3
pegunigalsidase alfa
Elfabrio (pegunigalsidase alfa)
Fabry Disease
Chiesi Farmaceutici SpA
0 catalysts
Phase 3
pelabresib
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Bromodomain and extra-terminal motif (BET)
$NVSNOVARTIS AG
0 catalysts
Phase 3
pemafibrate
pemafibrate [INN]
Hypertriglyceridemia
Kowa Co Ltd
0 catalysts
Phase 3
pentosan polysulfate sodium
Elmiron (pentosan polysulfate sodium)
Osteoarthritis
Paradigm Biopharmaceuticals Ltd
0 catalysts
Phase 3
petosemtamab
Recurrent Head And Neck Squamous Cell Carcinoma
Merus NV
0 catalysts
Phase 3
piclidenoson
Plaque Psoriasis (Psoriasis Vulgaris)
Adenosine receptor A3
$CANFCan-Fite BioPharma Ltd.
0 catalysts
Phase 3
pipamperone dihydrochloride
Major Depressive Disorder
AneuroTech
0 catalysts